was read the article
array:21 [ "pii" => "X2013251413053229" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2013.Jul.12103" "estado" => "S300" "fechaPublicacion" => "2013-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2013;33:862-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4953 "formatos" => array:3 [ "EPUB" => 330 "HTML" => 4057 "PDF" => 566 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699513053221" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2013.Jul.12103" "estado" => "S300" "fechaPublicacion" => "2013-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2013;33:862-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7053 "formatos" => array:3 [ "EPUB" => 284 "HTML" => 6042 "PDF" => 727 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Riñón de mieloma: importancia de la valoración de respuesta mediante monitorización de cadenas ligeras libres en suero" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "862" "paginaFinal" => "864" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12103_19904_46050_es_12103_f1.jpg" "Alto" => 386 "Ancho" => 600 "Tamanyo" => 178432 ] ] "descripcion" => array:1 [ "es" => "Biopsias renales" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Adoración Martín-Gómez, Sergio A. García-Marcos, Mercedes Caba-Molina, M. Eugenia Palacios-Gómez, Mercedes Gómez-Morales, Carlos Claver-Ferré" "autores" => array:6 [ 0 => array:2 [ "nombre" => "M. Adoración" "apellidos" => "Martín-Gómez" ] 1 => array:2 [ "nombre" => "Sergio A." "apellidos" => "García-Marcos" ] 2 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Caba-Molina" ] 3 => array:2 [ "nombre" => "M. Eugenia" "apellidos" => "Palacios-Gómez" ] 4 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Gómez-Morales" ] 5 => array:2 [ "nombre" => "Carlos" "apellidos" => "Claver-Ferré" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251413053229" "doi" => "10.3265/Nefrologia.pre2013.Jul.12103" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413053229?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513053221?idApp=UINPBA000064" "url" => "/02116995/0000003300000006/v0_201502091357/X0211699513053221/v0_201502091358/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251413053210" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2013.Jul.12040" "estado" => "S300" "fechaPublicacion" => "2013-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2013;33:864-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4747 "formatos" => array:3 [ "EPUB" => 322 "HTML" => 3729 "PDF" => 696 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "864" "paginaFinal" => "866" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hemorragia digestiva alta por dabigatran en paciente con enfermedad renal crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12040_16025_53072_en_t1120402.jpg" "Alto" => 1220 "Ancho" => 1418 "Tamanyo" => 260652 ] ] "descripcion" => array:1 [ "en" => "Data of test on admission" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José J. Ribés-Cruz, Isidro Torregrosa-Maicas, Carmela Ramos-Tomás, Miguel A. Solís-Salguero, M. José Puchades-Montesa, Miguel A. González-Rico, Isabel Juan-García, Patricia Tomás-Simó, Sandra Tejedor-Alonso, Patricia Zambrano-Esteves, Alfonso Miguel-Carrasco" "autores" => array:11 [ 0 => array:2 [ "nombre" => "José J." "apellidos" => "Ribés-Cruz" ] 1 => array:2 [ "nombre" => "Isidro" "apellidos" => "Torregrosa-Maicas" ] 2 => array:2 [ "nombre" => "Carmela" "apellidos" => "Ramos-Tomás" ] 3 => array:2 [ "nombre" => "Miguel A." "apellidos" => "Solís-Salguero" ] 4 => array:2 [ "nombre" => "M. José" "apellidos" => "Puchades-Montesa" ] 5 => array:2 [ "nombre" => "Miguel A." "apellidos" => "González-Rico" ] 6 => array:2 [ "nombre" => "Isabel" "apellidos" => "Juan-García" ] 7 => array:2 [ "nombre" => "Patricia" "apellidos" => "Tomás-Simó" ] 8 => array:2 [ "nombre" => "Sandra" "apellidos" => "Tejedor-Alonso" ] 9 => array:2 [ "nombre" => "Patricia" "apellidos" => "Zambrano-Esteves" ] 10 => array:2 [ "nombre" => "Alfonso" "apellidos" => "Miguel-Carrasco" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699513053213" "doi" => "10.3265/Nefrologia.pre2013.Jul.12040" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699513053213?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413053210?idApp=UINPBA000064" "url" => "/20132514/0000003300000006/v0_201502091623/X2013251413053210/v0_201502091624/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251413053237" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2013.Jul.12178" "estado" => "S300" "fechaPublicacion" => "2013-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2013;33:861-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6456 "formatos" => array:3 [ "EPUB" => 351 "HTML" => 5321 "PDF" => 784 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "861" "paginaFinal" => "862" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12178_16025_48442_en_f112178.jpg" "Alto" => 478 "Ancho" => 657 "Tamanyo" => 226774 ] ] "descripcion" => array:1 [ "en" => "Arteriolar hyalinosis due to calcineurin inhibitor toxicity in a renal biopsy specimen." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Zafer Ercan, Mehmet E. Demir, Ozgur Merhametsiz, Ozlem Yayar, Turgay Ulas, Mehmet D. Ayli" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Zafer" "apellidos" => "Ercan" ] 1 => array:2 [ "nombre" => "Mehmet E." "apellidos" => "Demir" ] 2 => array:2 [ "nombre" => "Ozgur" "apellidos" => "Merhametsiz" ] 3 => array:2 [ "nombre" => "Ozlem" "apellidos" => "Yayar" ] 4 => array:2 [ "nombre" => "Turgay" "apellidos" => "Ulas" ] 5 => array:2 [ "nombre" => "Mehmet D." "apellidos" => "Ayli" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X021169951305323X" "doi" => "10.3265/Nefrologia.pre2013.Jul.12178" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169951305323X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413053237?idApp=UINPBA000064" "url" => "/20132514/0000003300000006/v0_201502091623/X2013251413053237/v0_201502091624/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "titulo" => "Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "862" "paginaFinal" => "864" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "M. Adoración Martín-Gómez, Sergio A. García-Marcos, Mercedes Caba-Molina, M. Eugenia Palacios-Gómez, Mercedes Gómez-Morales, Carlos Claver-Ferré" "autores" => array:6 [ 0 => array:4 [ "nombre" => "M. Adoración" "apellidos" => "Martín-Gómez" "email" => array:1 [ 0 => "doritamg@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Sergio A." "apellidos" => "García-Marcos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "nombre" => "Mercedes" "apellidos" => "Caba-Molina" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 3 => array:3 [ "nombre" => "M. Eugenia" "apellidos" => "Palacios-Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "Mercedes" "apellidos" => "Gómez-Morales" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 5 => array:3 [ "nombre" => "Carlos" "apellidos" => "Claver-Ferré" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Unidad de Nefrología, Hospital de Poniente, El Ejido, Almería " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Anatomía Patológica, Hospital Virgen de las Nieves, Granada, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Hematología, Hospital Torrecárdenas, Almería, " "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Riñón de mieloma: importancia de la valoración de respuesta mediante monitorización de cadenas ligeras libres en suero" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12103_16025_52992_en_f1121034.jpg" "Alto" => 894 "Ancho" => 1381 "Tamanyo" => 565789 ] ] "descripcion" => array:1 [ "en" => "Renal biopsies." ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor:</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">Renal failure is a common and serious complication of multiple myeloma (MM) that leads to a significant increase in morbidity and mortality,<span class="elsevierStyleSup">1</span> with myeloma kidney being the entity most commonly found in this type of patient. The extracorporeal clearance of light chains is considered a support for chemotherapy to decrease the risk of advanced chronic renal failure and the need for chronic renal replacement therapy. It also decreases overall mortality.<span class="elsevierStyleSup">2</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">CASE STUDY</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">A 46-year-old patient without any relevant history, presented at the Emergency Department with pain in his left testicle irradiating to the ipsilateral flank, with no accompanying fever or urinary symptoms. The physical examination was unremarkable except for high blood pressure. The ultrasound of the kidneys and testicles-prostate was without findings. We observed rapidly progressive renal function deterioration (creatinine 9.79mg/dl, 4.85g/24 proteinuria without active sediment) and progressive anaemia (Hb 8.1g/dl, mean corpuscular volume 88fl, mean corpuscular haemoglobin 31.1, mean corpuscular haemoglobin concentration 35.4). The immunological study (anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies, anti-GBM, anti-streptolysin O, rheumatoid factor, C3-4), viral serology and tumour markers were normal. Protein electrophoresis-immunofixation with immunoglobulin (Ig) A-kappa monoclonal band. IgG 317, IgA 1446, IgM 15mg/dl, free light chains: (FLC, Free-Lite<span class="elsevierStyleSup">® </span>nephelometer) kappa 4090ng/ml, lambda 1. Uric acid 10.8, LDH 269, calcium 10.2, albumin 3.3, B<span class="elsevierStyleInf">2</span> microglobulin 23,340. Liver profile, lipids and other blood count were normal. Nephropathy was anatomopathologically diagnosed due to kappa free light chain (K-FLC) casts (Figure 1A) and Durie-Salmon stage IIIB IgA-kappa MM, and the patient was treated with bortezomib-dexamethasone along with renal replacement therapy with Theralite<span class="elsevierStyleSup">® </span>high cut-off filter on alternate days.</p><p class="elsevierStylePara">For two consecutive months, the serum IgA figure decreased progressively and significantly, which was not the case for pre-dialysis K-FLC (Figure 2), but in a multidisciplinary clinical session, it was decided to continue with the treatment established in accordance with the Haematology department protocol and re-biopsy the kidney to assess whether to continue renal replacement therapy. In the second biopsy, we observed chronic mild intensity tubulointerstitial lesions (Figure 1B). We prescribed 6 further high cut-off dialysis cycles.</p><p class="elsevierStylePara">Three months after diagnosis, after 4 chemotherapy cycles, bortezomib was considered to be ineffective and was replaced by lenalidomide, adjusted according to renal function. Due to financial constraints, it was impossible to continue removing FLC by renal replacement therapy (with the patient having received a total of 18 sessions) and they remained on renal replacement therapy with conventional high flow dialysis. The efficacy of lenalidomide was confirmed (Task Force, SWOG and EMBT) and the patient continues to receive this drug three years after diagnosis along with renal replacement therapy.</p><p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara">Renal failure in MM occurs in 12%-20% of patients, with a mean survival of less than one year in dialysis.<span class="elsevierStyleSup">3</span> Cast nephropathy is the most common cause of renal failure, with measurement of FLC in blood being a very useful diagnostic tool.<span class="elsevierStyleSup">4</span> Chemotherapy has been the key to an improved prognosis in these patients in the last decade, with light chain synthesis decreasing, causing the reduction of FLC deposits in the renal tubule, which is ultimately responsible for the nephropathy. Furthermore, extracorporeal clearance techniques that remove light chains and therefore stop their contact with the renal tubule have been tested for decades as a supportive therapy, without success in terms of renal function recovery.<span class="elsevierStyleSup">5</span> Hutchison et al.<span class="elsevierStyleSup">2 </span>improved these results with a long 8-hour haemodialysis technique using high cut-off filters in which success was determined by early treatment.<span class="elsevierStyleSup">6</span></p><p class="elsevierStylePara">In this case, first-line chemotherapy was not effective, rendering extracorporeal clearance useless. The monitoring of kappa-FLC, not IgA, which decreased considerably from the start of treatment, seemed to indicate this therapeutic failure at all stages and the short half-life of light chains meant that monitoring them allowed us to detect changes in the tumour earlier than in whole Ig.<span class="elsevierStyleSup">7 </span>As such, we observed how, after each cycle, the amount of FLC decreased significantly and increased to similar amounts in the next measurement 48 hours later, which means that the clearance filter was doing its work, which was not the case for the synthesis inhibitor treatment, i.e. chemotherapy. The contradiction between IgA levels and K-FLC levels and the non-inclusion of this FLC monitoring in the response protocols delayed the re-assessment of the patient’s treatment, which in turn interrupted their recovery from the nephropathy. So, we should perhaps consider that a same clone of B cells may secrete different quantities of whole Ig and light chains. Mead et al. found a poor correlation between levels of whole Ig and FLC in mixed myelomas.<span class="elsevierStyleSup">8</span> This, or the existence of different B cell clones, some of which segregate IgA and others, light chains, is the physiopathological explanation that we attribute to this case. As such, we rightfully believed that, although IgA levels reflected a good response to treatment, K-FLC were indicating the opposite.</p><p class="elsevierStylePara">Until present, FLC monitoring has not been included in standard blood protocols for response to treatment, and as such, in most centres, only whole Ig is taken into account when assessing this response. Due to the long half-life of Ig, it is monitored monthly and the response is not assessed before the fourth cycle of chemotherapy, that is, between the third and fourth month after diagnosis. The haematological argument for not advancing the abovementioned assessment is that a delay in the diagnosis of therapeutic ineffectiveness of 4-6 weeks does not really affect the final outcome, as far as the medullary response is concerned.<span class="elsevierStyleSup">8</span> as nephrologists, we insist that the situation is different whenever there is a nephropathy due to light chains, since early diagnosis-treatment <span class="elsevierStyleItalic">is</span> vital in this case: we can cure medullary cell dyscrasia at a later stage, but we cannot do so for renal tubular cells, as demonstrated in the second biopsy carried out in our case.</p><p class="elsevierStylePara">Fortunately, more and more studies advocate the prognostic importance of FLC<span class="elsevierStyleSup">9</span> and the inclusion of their monitoring in these protocols, which could even save a re-biopsy of the medulla.<span class="elsevierStyleSup">7-11</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold"> </span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">CONCLUSION</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">Early chemotherapy and clearance of free light chains is fundamental in order for treatment to be effective in myeloma kidney. The monitoring of free light chains in blood helps to assess the therapeutic response. Good coordination between Nephrology and Haematology is essential for treatment to be effective in these patients.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara"> </p><p class="elsevierStylePara">The authors declare that they have no conflicts of interest related to the contents of this article.</p><p class="elsevierStylePara"><a href="grande/12103_16025_52992_en_f1121034.jpg" class="elsevierStyleCrossRefs"><img src="12103_16025_52992_en_f1121034.jpg" alt="Renal biopsies."></img></a></p><p class="elsevierStylePara">Figure 1. Renal biopsies.</p><p class="elsevierStylePara"><a href="grande/12103_16025_52994_en_f2121033.jpg" class="elsevierStyleCrossRefs"><img src="12103_16025_52994_en_f2121033.jpg" alt="Monitoring of kappa light chains and immunoglobulin A. "></img></a></p><p class="elsevierStylePara">Figure 2. Monitoring of kappa light chains and immunoglobulin A. </p>" "pdfFichero" => "P1-E562-S4415-A12103-EN.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439658" "palabras" => array:1 [ 0 => "Free light chains" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439660" "palabras" => array:1 [ 0 => "Myeloma kidney" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439662" "palabras" => array:1 [ 0 => "Multiple myeloma" ] ] ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12103_16025_52992_en_f1121034.jpg" "Alto" => 894 "Ancho" => 1381 "Tamanyo" => 565789 ] ] "descripcion" => array:1 [ "en" => "Renal biopsies." ] ] 1 => array:8 [ "identificador" => "fig2" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "12103_16025_52994_en_f2121033.jpg" "Alto" => 840 "Ancho" => 1288 "Tamanyo" => 293246 ] ] "descripcion" => array:1 [ "en" => "Monitoring of kappa light chains and immunoglobulin A." ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:11 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 2000;65:175-81." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hutchison CA, Bradwell A, Cook M, Basnayake K, Basu S, Harding S, et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 2009;4(4):745-54. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19339414" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Martín-Reyes G, Valera A, Frutos MA, Ramos B, Ordoñez V, López de Novales E. Supervivencia de pacientes con mieloma tratados con diálisis. Nefrologia 2003;23:131-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12778877" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Campos ML, Barbosa de Varvalho NM, Martín-Reyes G. Valor del ensayo de las cadenas ligeras libres en suero para los pacientes de gammapatías monoclonales e insuficiencia renal. Nefrologia 2012;32:15-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/22294000" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005;143:777-84. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16330788" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Martín-Reyes G, Toledo-Rojas R, Torres-Rueda A, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, et al. Tratamiento con hemodiálisis del fracaso renal agudo en el mieloma múltiple con filtros de alto poro (hig cut off). Nefrologia 2012;32:35-43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/22294003" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT. Serum test for assessment of patients with Bence Jones myeloma. Lancet 2003;361:489-91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12583950" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19020545" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kyrsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, et al. Prognostic value of serum free Light chain ratio at diagnosis in multiple myeloma. Br J Haematol 2007;137:240-3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17408464" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Harrouseau JL, Greil R, Kloke O. ESMO minimum clinical recommendations for diagnosis treatment and follow-up of multiple myeloma. Ann Oncol 2005;16 Suppl 1:i45-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15888750" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004;126:348-354. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15257706" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003300000006/v0_201502091623/X2013251413053229/v0_201502091624/en/main.assets" "Apartado" => array:4 [ "identificador" => "35437" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Brief Case Reports" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003300000006/v0_201502091623/X2013251413053229/v0_201502091624/en/P1-E562-S4415-A12103-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251413053229?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 7 | 11 |
2024 October | 41 | 30 | 71 |
2024 September | 73 | 26 | 99 |
2024 August | 87 | 62 | 149 |
2024 July | 69 | 33 | 102 |
2024 June | 72 | 43 | 115 |
2024 May | 89 | 29 | 118 |
2024 April | 88 | 39 | 127 |
2024 March | 49 | 25 | 74 |
2024 February | 44 | 35 | 79 |
2024 January | 59 | 29 | 88 |
2023 December | 40 | 28 | 68 |
2023 November | 51 | 30 | 81 |
2023 October | 48 | 37 | 85 |
2023 September | 61 | 20 | 81 |
2023 August | 62 | 24 | 86 |
2023 July | 51 | 19 | 70 |
2023 June | 50 | 28 | 78 |
2023 May | 38 | 38 | 76 |
2023 April | 27 | 12 | 39 |
2023 March | 45 | 18 | 63 |
2023 February | 28 | 24 | 52 |
2023 January | 39 | 21 | 60 |
2022 December | 57 | 31 | 88 |
2022 November | 44 | 31 | 75 |
2022 October | 37 | 42 | 79 |
2022 September | 43 | 31 | 74 |
2022 August | 59 | 41 | 100 |
2022 July | 52 | 45 | 97 |
2022 June | 39 | 34 | 73 |
2022 May | 44 | 39 | 83 |
2022 April | 54 | 58 | 112 |
2022 March | 64 | 50 | 114 |
2022 February | 54 | 32 | 86 |
2022 January | 53 | 32 | 85 |
2021 December | 51 | 36 | 87 |
2021 November | 45 | 33 | 78 |
2021 October | 92 | 32 | 124 |
2021 September | 63 | 37 | 100 |
2021 August | 69 | 35 | 104 |
2021 July | 62 | 25 | 87 |
2021 June | 30 | 23 | 53 |
2021 May | 40 | 28 | 68 |
2021 April | 117 | 47 | 164 |
2021 March | 83 | 32 | 115 |
2021 February | 65 | 15 | 80 |
2021 January | 45 | 16 | 61 |
2020 December | 40 | 9 | 49 |
2020 November | 49 | 12 | 61 |
2020 October | 39 | 19 | 58 |
2020 September | 34 | 7 | 41 |
2020 August | 43 | 11 | 54 |
2020 July | 57 | 15 | 72 |
2020 June | 65 | 8 | 73 |
2020 May | 60 | 10 | 70 |
2020 April | 40 | 13 | 53 |
2020 March | 63 | 13 | 76 |
2020 February | 69 | 15 | 84 |
2020 January | 71 | 13 | 84 |
2019 December | 70 | 19 | 89 |
2019 November | 60 | 20 | 80 |
2019 October | 28 | 6 | 34 |
2019 September | 52 | 18 | 70 |
2019 August | 40 | 19 | 59 |
2019 July | 41 | 23 | 64 |
2019 June | 52 | 11 | 63 |
2019 May | 41 | 18 | 59 |
2019 April | 76 | 26 | 102 |
2019 March | 33 | 25 | 58 |
2019 February | 34 | 13 | 47 |
2019 January | 34 | 21 | 55 |
2018 December | 90 | 34 | 124 |
2018 November | 122 | 16 | 138 |
2018 October | 106 | 22 | 128 |
2018 September | 79 | 19 | 98 |
2018 August | 57 | 19 | 76 |
2018 July | 50 | 21 | 71 |
2018 June | 54 | 17 | 71 |
2018 May | 42 | 14 | 56 |
2018 April | 40 | 10 | 50 |
2018 March | 56 | 7 | 63 |
2018 February | 56 | 6 | 62 |
2018 January | 46 | 8 | 54 |
2017 December | 65 | 9 | 74 |
2017 November | 38 | 5 | 43 |
2017 October | 33 | 5 | 38 |
2017 September | 36 | 11 | 47 |
2017 August | 48 | 11 | 59 |
2017 July | 38 | 11 | 49 |
2017 June | 37 | 10 | 47 |
2017 May | 34 | 9 | 43 |
2017 April | 57 | 6 | 63 |
2017 March | 52 | 3 | 55 |
2017 February | 44 | 5 | 49 |
2017 January | 13 | 4 | 17 |
2016 December | 55 | 10 | 65 |
2016 November | 58 | 5 | 63 |
2016 October | 87 | 6 | 93 |
2016 September | 124 | 11 | 135 |
2016 August | 169 | 8 | 177 |
2016 July | 195 | 6 | 201 |
2016 June | 119 | 0 | 119 |
2016 May | 148 | 0 | 148 |
2016 April | 109 | 0 | 109 |
2016 March | 118 | 0 | 118 |
2016 February | 121 | 0 | 121 |
2016 January | 119 | 0 | 119 |
2015 December | 119 | 0 | 119 |
2015 November | 113 | 0 | 113 |
2015 October | 98 | 0 | 98 |
2015 September | 70 | 0 | 70 |
2015 August | 83 | 0 | 83 |
2015 July | 75 | 0 | 75 |
2015 June | 48 | 0 | 48 |
2015 May | 64 | 0 | 64 |
2015 April | 7 | 0 | 7 |